Monte Rosa Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Monte Rosa Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monte Rosa Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monte Rosa Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $160k | 30k | 5.32 |
| 2024-06-30 | $36k | 9.5k | 3.73 |
| 2024-03-31 | $42k | 5.9k | 7.05 |
| 2023-12-31 | $24k | 4.4k | 5.50 |
| 2023-09-30 | $3.4k | 707 | 4.79 |
| 2023-03-31 | $8.1k | 1.0k | 7.79 |
| 2022-12-31 | $10k | 1.3k | 7.61 |
| 2022-09-30 | $12k | 1.5k | 7.95 |
| 2021-12-31 | $98k | 4.8k | 20.40 |